Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
Deutsche Version Deutsche Version
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
Krebsforschung_EN.png
 
 
 
Hauptnavigation
  • Home
  • General Information
    • History
    • 50 years Institute for Cancer Research
    • Imagevideo: Institute for Cancer Research
  • Research
    • Research Focus
    • Research Laboratories
    • Scientific Services - Core Facilities
  • Teaching
    • Lectures of the Institute of Cancer Research
    • University Course Toxicology for Postgraduates
    • PhD Program Inflammation and Immunity
    • PhD Program IPPTO Translational Oncology
    • PhD Program Malignant Diseases
    • PhD Program Clinical and Experimental Oncology
  • Contact
    • Contact
    • Map
 
Research / Research Focus / Cellular and Molecular Tumorbiology
 
Subnavigation
  • Research Focus
    • Cellular and Molecular Tumorbiology
      • Maria Sibilia
      • Robert Eferl
      • Andrea Gsur
      • Erich Heidenreich
      • Dietmar Herndler-Brandstetter
      • Joanna Loizou
      • Ferdinand Steinböck
    • Applied and Experimental Oncology
    • Chemical Safety and Cancer Prevention
    • Tumor Progression and Metastasis
  • Research Laboratories
  • Scientific Services - Core Facilities


Inhaltsbereich

Cellular and Molecular Tumor Biology

(Head: Maria Sibilia, Univ.-Prof. Mag. Dr.)

In the recent years evidence accumulated that efficient tumor growth and metastasis is based on the complex interaction and signaling between mutated tumor cells and their “microenvironment” consisting of various cell types including immune cells, vascular cells, and fibroblasts. We use different model systems and patient material to identify these signaling pathways, especially in liver and colorectal cancers. Currently, we are focusing on pathways like EGFR-, FGF-, and Jak-Stat-signaling to understand their important role in tumor and stroma cells. Using both, in vitro and in vivo models we aim to develop effective new targeted treatments and to simultaneously attack multiple pathways in cancer cells and the tumor stroma which are most likely required to prevent uncontrollable tumor growth.

FWF Video

Immune research for improved cancer therapies from Wissenschaftsfonds FWF on Vimeo.

 
Print
 
 
© MedUni Wien | Publishing information | Terms of use | Data Protection | Accessibility | Contact